Reanimon (neonatal respiratory support machine)

2023: Market Entry

Schwabe registered the neonatal respiratory support apparatus Reanimon. The press service of Rostec (this state corporation includes the Schwabe holding) announced this on October 9, 2023.

The device, developed by specialists of the Ural Optical and Mechanical Plant named after E.S. Yalamov (UOMZ), is designed for non-invasive respiratory therapy and ventilation of the lungs. The device has four modes of operation, including the possibility of short-term invasive and non-invasive ventilation through a T-shaped connector. This approach, according to the developers, reduces the risk of developing chronic pulmonary diseases by maintaining constant pressure in the respiratory tract. The device also has a built-in pulse oximeter, a cardiopulmonary resuscitation metronome and an apgar timer to assess the patient's condition, the Rostec press service added.

Schwabe registers neonatal respiratory support machine Reanimon

According to Lev Borisov, Deputy General Director of Schwabe, the first Reanimon samples will be released to the market in the first quarter of 2024. Our next step is to master mass production, he stressed.

I note that the device is designed to work in intensive care units in maternity hospitals and perinatal centers, Borisov added (quoted by the Rostec press service).

Ural Optical and Mechanical Plant named after E.S. Yalamova is one of the oldest Ural manufacturers of medical devices. The plant specializes in neonatal equipment, produces incubators, heaters, irradiators for phototherapy, breathing support devices. In September 2023, the company modernized production, reducing the share of foreign components. For these purposes, 25 million rubles were allocated from the budget of the Sverdlovsk region in 2022.^[1]

Notes